Brief: Phasebio Names Jonathan Birchall As Chief Commercial Officer
18/11/2021 21:49
Nov 18 (Reuters) - PhaseBio Pharmaceuticals Inc PHAS.O :
* PHASEBIO NAMES JONATHAN BIRCHALL AS CHIEF COMMERCIAL
OFFICER
Source text for Eikon: ID:nBwPlVc1a
Further company coverage: PHAS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PhaseBio Pharmaceuticals
See all newsBrief: Phasebio Pharmaceuticals Says Bankruptcy Court Entered Order Approving 1st Amended Combined Disclosure Statement & Chapter 11 Plan On Final Basis
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
PhaseBio Pharma slips on bankruptcy plans